Human cytomegalovirus UL97 D605E polymorphism has a high prevalence in immunocompetent Japanese infants and children

Microbiology and Immunology

Volumn 55, Issue 5, 2011, Pages 328-330

  Tanaka, Kaori ^a   Hori, Tsukasa ^a   Yoto, Yuko ^a   Hatakeyama, Naoki ^a   Yamamoto, Masaki ^a   Suzuki, Nobuhiro ^a   Tsutsumi, Hiroyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytomegalovirus; Ganciclovir; Molecular epidemiology; UL97 polymorphism

Indexed keywords

ASPARTIC ACID; GANCICLOVIR; GLUTAMIC ACID;

ANTIVIRAL RESISTANCE; ARTICLE; CHILD; CODON; CYTOMEGALOVIRUS INFECTION; DNA POLYMORPHISM; GENE MUTATION; GENE SEQUENCE; GENETIC MARKER; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOCOMPETENCE; INFANT; JAPANESE; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; UL97 GENE; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTATION; VIRUS STRAIN;

ANTIVIRAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CODON; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE, VIRAL; GANCICLOVIR; HUMANS; IMMUNOCOMPETENCE; INFANT; MOLECULAR EPIDEMIOLOGY; MUTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, GENETIC;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 79955149907     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00327.x     Document Type: Article

References (20)

1. Sanchez Puch S., Ochoa C., Carballal G., Zala C., Chan P., Brunet R., Salomon H., Videla C. (2004) Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina. J Clin Virol 30: 271-5.
2. Erice A., Borrell N., Li W., Miller W.J., Balfour H.H. Jr. (1998) Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis. J Infect Dis 178: 531-4.
3. Gilbert C., Boivin G. (2005) Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother 49: 873-83.
4. Gilbert C., Bestman-Smith J., Boivin G. (2002) Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Update 5: 88-114.
5. Castor J., Cook L., Corey L., Jerome K.R. (2007) Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance. J Clin Microbiol 45: 2681-83.
6. Gilbert C., Handfield J., Toma E., Lalonde R., Bergeron M.G., Boivin G. (1998) Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients. AIDS 12: 125-9.
7. Chou S. (1999) Antiviral drug resistance in human cytomegalovirus. Trancepl Infect Dis 1: 105-14.
8. Chou S., Meichsner C.L. (2000) A nine-codon deletion mutation in the cytomegalovirus UL97 phosphotransferase gene confers resistance to ganciclovir. Antimicrob Agents Chemother 44: 183-5.
9. Chou S., Waldemer R.H., Senters A.E., Michels K.S., Kemble G.W., Miner R.C., Drew W.L. (2002) Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir. J Infect Di 185: 162-9.
10. Hamprecht K., Eckle T., Prix L., Faul C., Einsele H., Jahn G. (2002) Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfall of phenotypic diagnosis by in vitro selection of an UL97 mutant strain. J Infect Dis 187: 139-43.
11. Eckle T., Jahn G., Hamprecht K. (2003) High impact of an expanded restriction fragment length polymorphism assay on detection of ganciclovir-resistant UL97 mutants of human cytomegalovirus. Antimicrob Agents Chemother 47: 442-3.
12. Zhou L., Fan J., Zheng S.S., Ma W.H. (2006) Prevalence of human cytomegalovirus UL97 D605E mutation in transplant recipients in China. Transplant Proc 38: 2926-8.
13. Kumar S., Tamura K., Nei M. (2004) MEGA 3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5: 150-63.
14. Alain S., Mazeron M.C., Pepin J.M., Brgmann J.F., Narwa R., Raskine L., Sanson Le Pors M.J. (1995) Value of a new rapid non-radioactive sequencing method for analysis of the cytomegalovirus UL97 gene in ganciclovir-resistant strains. J Viol Methods 51: 241-52.
15. Hu H., Jabs D.A., Forman M.S., Martin B.K., Dunn J.P., Weinberg D.V., Davis J.L. (2002) Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis. J Infect Dis 185: 861-7.
16. Sanchez Puch S.I., Mathet V.L., Porta M., Cuestas M.L., Oubina J.R., Videla C.M., Salomon H.E. (2009) Single and multiple mutations in the human cytomegalovirus UL97 gene and their relationship to the enzymatic activity of UL97 kinase for ganciclovir phosphorylation. Antiviral Res 84: 194-8.
17. Oyarzun M.A., Bustos P., Gonzalez M., Dominguez M.I., Aguayo F., Nervi B., Ferres M. (2010) Presence of mutations associated with ganciclovir resistance in cytomegalovirus UL97 gene. Rev Med Chile 138: 421-7.
18. Ijichi O., Michel D., Mertens T., Miyama K., Eizuru Y. (2002) GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E. Antiviral Res 53: 135-42.
19. Chou S., Van Wechel L.C., Lichy H.M., Marousek G.I. (2005) Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene. Antimicrob Agents Chemother 49: 2710-5.
20. Tanaka K., Numazaki K., Tsutsumi H. (2005) Human cytomegalovirus genetic variability in strains isolated from Japanese children during 1983-2003. J Med Virol 73: 356-60.